神経科学用抗体及びアッセイの世界市場2020-2024

◆英語タイトル:Global Neuroscience Antibodies and Assays Market 2020-2024
◆商品コード:TNV20FB063
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年1月16日
◆ページ数:120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥420,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

「神経科学用抗体及びアッセイの世界市場2020-2024」は、神経科学用抗体及びアッセイについて市場概要、市場規模、製品別(消耗品、機器)分析、顧客状況、地域状況、市場の要因・課題、市場トレンド、企業状況、企業分析などを総合的にまとめて調査・分析したものです。
・エグゼクティブサマリー
・レポート範囲
・市場概要
・市場規模
・ファイブフォース分析
・神経科学用抗体及びアッセイの世界市場:製品別(消耗品、機器)
・顧客状況
・地域状況
・市場の要因・課題
・市場トレンド
・企業状況
・企業分析
【レポートの概要】

Global Neuroscience Antibodies and Assays Market 2020-2024
Technavio has been monitoring the global neuroscience antibodies and assays market and it is poised to grow by USD 1.36 bn during 2020-2024, progressing at a CAGR of 8% during the forecast period. Our reports on global neuroscience antibodies and assays market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by technological advances. In addition, advances in neuroscience instruments is anticipated to boost the growth of the global neuroscience antibodies and assays market as well.

Market Segmentation

Technavio’s global neuroscience antibodies and assays market is segmented as below:
Product
• Consumables
• Instruments

Geographic segmentation
• Asia
• Europe
• North America
• ROW

Key Trends for global neuroscience antibodies and assays market growth
This study identifies advances in neuroscience instruments as the prime reasons driving the global neuroscience antibodies and assays market growth during the next few years.

Prominent vendors in global neuroscience antibodies and assays market
We provide a detailed analysis of around 25 vendors operating in the global neuroscience antibodies and assays market, including some of the vendors such as Abcam Plc, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche Ltd., GenScript Biotech Corp., Merck KGaA, Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Tecan Group Ltd. and Thermo Fisher Scientific Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit -https://www.technavio.com/report/Global-Neuroscience-Antibodies-and-Assays-Market-industry-analysis

【レポートの目次】

01: EXECUTIVE SUMMARY
02: SCOPE OF THE REPORT
1. 2.1 Preface
2. 2.2 Currency conversion rates for US$
03: MARKET LANDSCAPE
3. Market ecosystem
4. Market characteristics
5. Market segmentation analysis
04: MARKET SIZING
6. Market definition
7. Market sizing 2019
8. Market outlook
9. Market size and forecast 2019-2024
05: FIVE FORCES ANALYSIS
10. Bargaining power of buyers
11. Bargaining power of suppliers
12. Threat of new entrants
13. Threat of substitutes
14. Threat of rivalry
15. Market condition
06: MARKET SEGMENTATION BY PRODUCT
16. Market segmentation by product
17. Comparison by product
18. Consumables – Market size and forecast 2019-2024
19. Instruments – Market size and forecast 2019-2024
20. Market opportunity by product
07: CUSTOMER LANDSCAPE
08: GEOGRAPHIC LANDSCAPE
21. Geographic segmentation
22. Geographic comparison
23. North America – Market size and forecast 2019-2024
24. Europe – Market size and forecast 2019-2024
25. Asia – Market size and forecast 2019-2024
26. ROW – Market size and forecast 2019-2024
27. Key leading countries
28. Market opportunity
09: DRIVERS AND CHALLENGES
29. Market drivers
30. Market challenges
10: MARKET TRENDS
31. High growth potential in emerging countries
32. Increasing focus on neurological disease research
33. Advances in neuroscience instruments
11: VENDOR LANDSCAPE
34. Overview
35. Landscape disruption
36. Competitive scenario
12: VENDOR ANALYSIS
37. Vendors covered
38. Vendor classification
39. Market positioning of vendors
40. Abcam Plc
41. Bio-Rad Laboratories Inc.
42. Cell Signaling Technology Inc.
43. F. Hoffmann-La Roche Ltd.
44. GenScript Biotech Corp.
45. Merck KGaA
46. Rockland Immunochemicals Inc.
47. Santa Cruz Biotechnology Inc.
48. Tecan Group Ltd.
49. Thermo Fisher Scientific Inc.
13: APPENDIX
50. Research methodology
51. List of abbreviations
52. Definition of market positioning of vendors
14: EXPLORE TECHNAVIO


Exhibit 01: Global life sciences tools and services market
Exhibit 02: Segments of global life sciences tools and services market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Product – Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Consumables – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Consumables – Year-over-year growth 2020-2024 (%)
Exhibit 22: Instruments – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Instruments – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Number of people aged 65 years and above in EU countries in 2005 and 2018 (in millions)
Exhibit 31: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 33: Number of people aged 65 years and above in Asian countries in 2005 and 2018 (in millions)
Exhibit 34: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 36: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 37: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abcam Plc – Vendor overview
Exhibit 47: Abcam Plc – Business segments
Exhibit 48: Abcam Plc – Organizational developments
Exhibit 49: Abcam Plc – Geographic focus
Exhibit 50: Abcam Plc – Key offerings
Exhibit 51: Bio-Rad Laboratories Inc. – Vendor overview
Exhibit 52: Bio-Rad Laboratories Inc. – Business segments
Exhibit 53: Bio-Rad Laboratories Inc. – Organizational developments
Exhibit 54: Bio-Rad Laboratories Inc. – Geographic focus
Exhibit 55: Bio-Rad Laboratories Inc. – Segment focus
Exhibit 56: Bio-Rad Laboratories Inc. – Key offerings
Exhibit 57: Cell Signaling Technology Inc. – Vendor overview
Exhibit 58: Cell Signaling Technology Inc. – Business segments
Exhibit 59: Cell Signaling Technology Inc. – Organizational developments
Exhibit 60: Cell Signaling Technology Inc. – Key offerings
Exhibit 61: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 62: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 63: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 64: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 65: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 66: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 67: GenScript Biotech Corp. – Vendor overview
Exhibit 68: GenScript Biotech Corp. – Business segments
Exhibit 69: GenScript Biotech Corp. – Organizational developments
Exhibit 70: GenScript Biotech Corp. – Geographic focus
Exhibit 71: GenScript Biotech Corp. – Segment focus
Exhibit 72: GenScript Biotech Corp. – Key offerings
Exhibit 73: Merck KGaA – Vendor overview
Exhibit 74: Merck KGaA – Business segments
Exhibit 75: Merck KGaA – Organizational developments
Exhibit 76: Merck KGaA – Geographic focus
Exhibit 77: Merck KGaA – Segment focus
Exhibit 78: Merck KGaA – Key offerings
Exhibit 79: Rockland Immunochemicals Inc. – Vendor overview
Exhibit 80: Rockland Immunochemicals Inc. – Business segments
Exhibit 81: Rockland Immunochemicals Inc. – Organizational developments
Exhibit 82: Rockland Immunochemicals Inc. – Key offerings
Exhibit 83: Santa Cruz Biotechnology Inc. – Vendor overview
Exhibit 84: Santa Cruz Biotechnology Inc. – Business segments
Exhibit 85: Santa Cruz Biotechnology Inc. – Key offerings
Exhibit 86: Tecan Group Ltd. – Vendor overview
Exhibit 87: Tecan Group Ltd. – Business segments
Exhibit 88: Tecan Group Ltd. – Organizational developments
Exhibit 89: Tecan Group Ltd. – Geographic focus
Exhibit 90: Tecan Group Ltd. – Segment focus
Exhibit 91: Tecan Group Ltd. – Key offerings
Exhibit 92: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 93: Thermo Fisher Scientific Inc. – Business segments
Exhibit 94: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 95: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 96: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 97: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 98: Validation techniques employed for market sizing
Exhibit 99: Definition of market positioning of vendors



【掲載企業】

Abcam Plc
Bio-Rad Laboratories Inc.
Cell Signaling Technology Inc.
F. Hoffmann-La Roche Ltd.
GenScript Biotech Corp.

Merck KGaA

Rockland Immunochemicals Inc.

Santa Cruz Biotechnology Inc.

Tecan Group Ltd.

Thermo Fisher Scientific Inc.137

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[神経科学用抗体及びアッセイの世界市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆